✦ LIBER ✦

Linagliptin for patients aged 70 years or older with type 2 diabetes inadequately controlled with common antidiabetes treatments: a randomised, double-blind, placebo-controlled trial

✍ Scribed by Barnett, Anthony H; Huisman, Holger; Jones, Russell; von Eynatten, Maximilian; Patel, Sanjay; Woerle, Hans-Juergen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of dapagliflozin in patients with

✍ Clifford J Bailey; Jorge L Gross; Anne Pieters; Arnaud Bastien; James F List 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 260 KB

2-year efficacy and safety of linaglipti

✍ Baptist Gallwitz; Julio Rosenstock; Thomas Rauch; Sudipta Bhattacharya; Sanjay P 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 289 KB

Efficacy and safety of linagliptin 2.5 m

✍ Ross, Stuart A.; Rafeiro, Elizabeth; Meinicke, Thomas; Toorawa, Robert; Weber-Bo 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 254 KB

Efficacy and safety of empagliflozin add

✍ Barnett, Anthony H; Mithal, Ambrish; Manassie, Jenny; Jones, Russell; Rattunde, 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 632 KB

Lixisenatide treatment improves glycaemi

✍ Yu Pan, Chang ;Han, Ping ;Liu, Xiaoming ;Yan, Shengli ;Feng, Ping ;Zhou, Zhiguan 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 650 KB

Linagliptin monotherapy in type 2 diabet

✍ Barnett, A. H.; Patel, S.; Harper, R.; Toorawa, R.; Thiemann, S.; von Eynatten, 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 619 KB